Systemic anti-S IgA antibodies, and anti-N IgG antibodies were only observed after the mucosal Ad5 boost, and Delta virus breakthrough infection (Fig. 1b), and were in both groups significantly higher than in the mucosal LAV group at week 18 (Fig. 1b). Here, CD79A is linked to infection.